Shao N, Jiang WY, Qiao D, Zhang SG, Wu Y, Zhang XX, Hua LX, Ding Y, Feng NH (2012). "An updated meta-analysis of XRCC4 polymorphisms and cancer risk based on 31 case-control studies". Cancer Biomark12 (1): 37–47. PMID23321468. doi:10.3233/CBM-120292.
De Bont R, van Larebeke N (maio de 2004). "Endogenous DNA damage in humans: a review of quantitative data". Mutagenesis19 (3): 169–85. PMID15123782. doi:10.1093/mutage/geh025.
Lieber MR, Lu H, Gu J, Schwarz K (xaneiro de 2008). "Flexibility in the order of action and in the enzymology of the nuclease, polymerases, and ligase of vertebrate non-homologous DNA end joining: relevance to cancer, aging, and the immune system". Cell Res.18 (1): 125–33. PMID18087292. doi:10.1038/cr.2007.108.
Mittal RD, Gangwar R, Mandal RK, Srivastava P, Ahirwar DK (febreiro de 2012). "Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer". Mol. Biol. Rep.39 (2): 1667–75. PMID21617942. doi:10.1007/s11033-011-0906-z.
Zhou LP, Luan H, Dong XH, Jin GJ, Ma DL, Shang H (2012). "Association of functional polymorphisms of the XRCC4 gene with the risk of breast cancer: a meta-analysis". Asian Pac. J. Cancer Prev.13 (7): 3431–6. PMID22994773. doi:10.7314/APJCP.2012.13.7.3431.
Cifci S, Yilmaz M, Pehlivan M, Sever T, Okan V, Pehlivan S (novembro de 2011). "DNA repair genes polymorphisms in multiple myeloma: no association with XRCC1 (Arg399Gln) polymorphism, but the XRCC4 (VNTR in intron 3 and G-1394T) and XPD (Lys751Gln) polymorphisms is associated with the disease in Turkish patients". Hematology16 (6): 361–7. PMID22183071. doi:10.1179/102453311X13127324303399.
Mandal RK, Singh V, Kapoor R, Mittal RD (maio de 2011). "Do polymorphisms in XRCC4 influence prostate cancer susceptibility in North Indian population?". Biomarkers16 (3): 236–42. PMID21506695. doi:10.3109/1354750X.2010.547599.
Wu CN, Liang SY, Tsai CW, Bau DT (novembro de 2008). "The role of XRCC4 in carcinogenesis and anticancer drug discovery". Recent Pat Anticancer Drug Discov3 (3): 209–19. PMID18991789. doi:10.2174/157489208786242304.
Lee KJ, Dong X, Wang J, Takeda Y, Dynan WS (setembro de 2002). "Identification of human autoantibodies to the DNA ligase IV/XRCC4 complex and mapping of an autoimmune epitope to a potential regulatory region". J. Immunol.169 (6): 3413–21. PMID12218164. doi:10.4049/jimmunol.169.6.3413.
Takeda Y, Dynan WS (novembro de 2001). "Autoantibodies against DNA double-strand break repair proteins". Front. Biosci.6: D1412–22. PMID11689355. doi:10.2741/Takeda.
Hsieh YY, Bau DT, Chang CC, Tsai CH, Chen CP, Tsai FJ (maio de 2008). "XRCC4 codon 247*A and XRCC4 promoter -1394*T related genotypes but not XRCC4 intron 3 gene polymorphism are associated with higher susceptibility for endometriosis". Mol. Reprod. Dev.75 (5): 946–51. PMID18246529. doi:10.1002/mrd.20829.
Zheng Z, Ng WL, Zhang X, Olson JJ, Hao C, Curran WJ, Wang Y (marzo de 2012). "RNAi-mediated targeting of noncoding and coding sequences in DNA repair gene messages efficiently radiosensitizes human tumor cells". Cancer Res.72 (5): 1221–8. PMID22237628. doi:10.1158/0008-5472.CAN-11-2785.
Rosin N, Elcioglu NH, Beleggia F, Isgüven P, Altmüller J, Thiele H, Steindl K, Joset P, Rauch A, Nürnberg P, Wollnik B, Yigit G (Apr 2015). "Mutations in XRCC4 cause primary microcephaly, short stature and increased genomic instability". Human Molecular Genetics24: 3708–17. PMID25839420. doi:10.1093/hmg/ddv115.
Massip L, Caron P, Iacovoni JS, Trouche D, Legube G (agosto de 2010). "Deciphering the chromatin landscape induced around DNA double strand breaks". Cell Cycle9 (15): 2963–72. PMID20714222. doi:10.4161/cc.9.15.12412.
Giaccia A, Weinstein R, Hu J, Stamato TD (setembro de 1985). "Cell cycle-dependent repair of double-strand DNA breaks in a gamma-ray-sensitive Chinese hamster cell". Somat. Cell Mol. Genet.11 (5): 485–91. PMID3862244. doi:10.1007/BF01534842.
Stamato TD, Dipatri A, Giaccia A (agosto de 1988). "Cell-cycle-dependent repair of potentially lethal damage in the XR-1 gamma-ray-sensitive Chinese hamster ovary cell". Radiat. Res.115 (2): 325–33. PMID3406371. doi:10.2307/3577168.
Giaccia AJ, Richardson E, Denko N, Stamato TD (xaneiro de 1989). "Genetic analysis of XR-1 mutation in hamster and human hybrids". Somat. Cell Mol. Genet.15 (1): 71–7. PMID2916163. doi:10.1007/BF01534671.
Shao N, Jiang WY, Qiao D, Zhang SG, Wu Y, Zhang XX, Hua LX, Ding Y, Feng NH (2012). "An updated meta-analysis of XRCC4 polymorphisms and cancer risk based on 31 case-control studies". Cancer Biomark12 (1): 37–47. PMID23321468. doi:10.3233/CBM-120292.
De Bont R, van Larebeke N (maio de 2004). "Endogenous DNA damage in humans: a review of quantitative data". Mutagenesis19 (3): 169–85. PMID15123782. doi:10.1093/mutage/geh025.
Lieber MR, Lu H, Gu J, Schwarz K (xaneiro de 2008). "Flexibility in the order of action and in the enzymology of the nuclease, polymerases, and ligase of vertebrate non-homologous DNA end joining: relevance to cancer, aging, and the immune system". Cell Res.18 (1): 125–33. PMID18087292. doi:10.1038/cr.2007.108.
Popławski T, Stoczyńska E, Błasiak J (2009). "[Non-homologous DNA end joining--new proteins, new functions, new mechanisms]". Postepy Biochem.(en Polish)55 (1): 36–45. PMID19514464.
Mittal RD, Gangwar R, Mandal RK, Srivastava P, Ahirwar DK (febreiro de 2012). "Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer". Mol. Biol. Rep.39 (2): 1667–75. PMID21617942. doi:10.1007/s11033-011-0906-z.
Zhou LP, Luan H, Dong XH, Jin GJ, Ma DL, Shang H (2012). "Association of functional polymorphisms of the XRCC4 gene with the risk of breast cancer: a meta-analysis". Asian Pac. J. Cancer Prev.13 (7): 3431–6. PMID22994773. doi:10.7314/APJCP.2012.13.7.3431.
Cifci S, Yilmaz M, Pehlivan M, Sever T, Okan V, Pehlivan S (novembro de 2011). "DNA repair genes polymorphisms in multiple myeloma: no association with XRCC1 (Arg399Gln) polymorphism, but the XRCC4 (VNTR in intron 3 and G-1394T) and XPD (Lys751Gln) polymorphisms is associated with the disease in Turkish patients". Hematology16 (6): 361–7. PMID22183071. doi:10.1179/102453311X13127324303399.
Mandal RK, Singh V, Kapoor R, Mittal RD (maio de 2011). "Do polymorphisms in XRCC4 influence prostate cancer susceptibility in North Indian population?". Biomarkers16 (3): 236–42. PMID21506695. doi:10.3109/1354750X.2010.547599.
Wu CN, Liang SY, Tsai CW, Bau DT (novembro de 2008). "The role of XRCC4 in carcinogenesis and anticancer drug discovery". Recent Pat Anticancer Drug Discov3 (3): 209–19. PMID18991789. doi:10.2174/157489208786242304.
Lee KJ, Dong X, Wang J, Takeda Y, Dynan WS (setembro de 2002). "Identification of human autoantibodies to the DNA ligase IV/XRCC4 complex and mapping of an autoimmune epitope to a potential regulatory region". J. Immunol.169 (6): 3413–21. PMID12218164. doi:10.4049/jimmunol.169.6.3413.
Takeda Y, Dynan WS (novembro de 2001). "Autoantibodies against DNA double-strand break repair proteins". Front. Biosci.6: D1412–22. PMID11689355. doi:10.2741/Takeda.
Hsieh YY, Bau DT, Chang CC, Tsai CH, Chen CP, Tsai FJ (maio de 2008). "XRCC4 codon 247*A and XRCC4 promoter -1394*T related genotypes but not XRCC4 intron 3 gene polymorphism are associated with higher susceptibility for endometriosis". Mol. Reprod. Dev.75 (5): 946–51. PMID18246529. doi:10.1002/mrd.20829.
Zheng Z, Ng WL, Zhang X, Olson JJ, Hao C, Curran WJ, Wang Y (marzo de 2012). "RNAi-mediated targeting of noncoding and coding sequences in DNA repair gene messages efficiently radiosensitizes human tumor cells". Cancer Res.72 (5): 1221–8. PMID22237628. doi:10.1158/0008-5472.CAN-11-2785.
Rosin N, Elcioglu NH, Beleggia F, Isgüven P, Altmüller J, Thiele H, Steindl K, Joset P, Rauch A, Nürnberg P, Wollnik B, Yigit G (Apr 2015). "Mutations in XRCC4 cause primary microcephaly, short stature and increased genomic instability". Human Molecular Genetics24: 3708–17. PMID25839420. doi:10.1093/hmg/ddv115.
Massip L, Caron P, Iacovoni JS, Trouche D, Legube G (agosto de 2010). "Deciphering the chromatin landscape induced around DNA double strand breaks". Cell Cycle9 (15): 2963–72. PMID20714222. doi:10.4161/cc.9.15.12412.
Giaccia A, Weinstein R, Hu J, Stamato TD (setembro de 1985). "Cell cycle-dependent repair of double-strand DNA breaks in a gamma-ray-sensitive Chinese hamster cell". Somat. Cell Mol. Genet.11 (5): 485–91. PMID3862244. doi:10.1007/BF01534842.
Stamato TD, Dipatri A, Giaccia A (agosto de 1988). "Cell-cycle-dependent repair of potentially lethal damage in the XR-1 gamma-ray-sensitive Chinese hamster ovary cell". Radiat. Res.115 (2): 325–33. PMID3406371. doi:10.2307/3577168.
Giaccia AJ, Richardson E, Denko N, Stamato TD (xaneiro de 1989). "Genetic analysis of XR-1 mutation in hamster and human hybrids". Somat. Cell Mol. Genet.15 (1): 71–7. PMID2916163. doi:10.1007/BF01534671.